Literature DB >> 24383910

Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis.

D Hirata1, T Nagashima, S Saito, H Okazaki, S Kano, S Minota.   

Abstract

Abstract We report a case of hypocalcemic myopathy confounded by polymyositis due to an elevated level of serum creatine kinase (CK). A 30-year-old man was referred to our hospital for the treatment of provisionally diagnosed polymyositis. His presentation with tetany, hyporeflexia, and general fatigue, in addition to muscle weakness on admission, prompted us to scrutinize a blood sample in search of secondary myopathy. Blood chemistry revealed an elevated level of serum CK, marked hypocalcemia, hyperphosphatemia, and a low serum level of intact parathyroid hormone. The Ellsworth Howard test confirmed the diagnosis of hypoparathyroidism. Supplementation with calcium and 1α-hydroxyvitamin D3 improved his muscle weakness rapidly, and his serum CK level returned to the normal range. Hypoparathyroidism should be included in differential diagnoses of elevated serum CK.

Entities:  

Year:  2002        PMID: 24383910     DOI: 10.3109/s101650200032

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations.

Authors:  S W Kim; N Hong; Y Rhee; Y-C Choi; H Y Shin; S M Kim
Journal:  Osteoporos Int       Date:  2018-04-05       Impact factor: 4.507

2.  Primary hypoparathyroidism accompanied by rhabdomyolysis induced by infection: A case report.

Authors:  Li-Na Ding; Yi Wang; Jun Tian; Li-Fang Ye; Shi Chen; Shi-Min Wu; Wen-Bin Shang
Journal:  World J Clin Cases       Date:  2019-10-06       Impact factor: 1.337

Review 3.  The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).

Authors:  N C Harvey; E Biver; J-M Kaufman; J Bauer; J Branco; M L Brandi; O Bruyère; V Coxam; A Cruz-Jentoft; E Czerwinski; H Dimai; P Fardellone; F Landi; J-Y Reginster; B Dawson-Hughes; J A Kanis; R Rizzoli; C Cooper
Journal:  Osteoporos Int       Date:  2016-10-20       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.